
Global data point to a softening but still mixed growth backdrop, with US manufacturing in mild contraction contrasted against resilient services activity. Labour indicators such as ADP employment and continuing jobless claims show cooling private hiring and more challenging re‑employment conditions, reinforcing expectations of earlier and deeper Federal Reserve rate cuts. Core US PCE inflation is running at a steady, moderate pace, allowing the Fed to stay on hold while waiting for clearer evidence that inflation is durably converging to the target.

The small-cap medical-tech company, Control Bionics, has just taken steps that could catapult it far beyond its current size. Its core product, a wearable sensor that translates even the faintest muscle or nerve signals into computer commands, is already approved and helps people with severe physical disabilities communicate and interact. Recently, the company announced that it had integrated a significant tech giant’s brain-computer interface protocol into its devices.

Investigator Silver (ASX: IVR), formerly known as Investigator Resources, is moving through one of the most strategically important phases in its history. The company is advancing the Paris Silver Project, Australia’s highest-grade undeveloped primary silver deposit, while simultaneously delivering exploration wins across its 100%-owned Peterlumbo tenement and progressing copper-gold targets at Uno Morgans.

NRW Holdings is emerging from FY25 with strengthened financial performance, record order book visibility, and renewed momentum across its mining, civil, and MET (Maintenance & Engineering) segments. With EBITDA growing, margins stabilising, and a robust pipeline supported by long-life Tier-1 resources projects, NWH has entered FY26 well-positioned for continued earnings expansion. The company’s durability across cycles, combined with strong cash generation and rising recurring revenue streams, reinforces the investment case for long-term holders.

When you spend enough time around the ASX, you start to notice a certain rhythm in how strong charts behave. Some stocks creep for weeks, building energy in tight ranges, and then, almost without announcement, they begin flashing early signs of strength. In this review, we focus on three ASX-listed companies whose price action suggests further upside.

Lithium prices are rising again, which tends to lift investor interest in ASX-listed producers. Thanks to growing demand for batteries (EVs, energy storage) and tightening supply, analysts suggest the recent price upswing, roughly 20–25% month-on-month, may mark a turning point. In that context, some ASX companies with solid operations and cash flow stand out as offering relatively better risk-adjusted opportunities. Still, it’s not a guaranteed path: lithium remains a volatile commodity, and gains now reflect renewed optimism rather than long-term certainty.